Pancreatic Cancer Research

ResearcherPeking University First HospitalActive in the last 2 years

Weikang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-3344-9228; OpenAlex author ID A5101832714. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocarcinoma via SLC7A11-mediated ferroptosis. Co-author DOI 10.1038/s41420-024-02035-x↗
  2. The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and meta-analysis. Co-author DOI 10.1007/s10238-023-01112-2↗
  3. Predictive Model of Early Death of Resectable Pancreatic Ductal Adenocarcinoma After Curative Resection: A SEER-Based Study. Co-author DOI 10.1177/10732748221084853↗
  4. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression. Co-author DOI 10.1016/j.ebiom.2021.103315↗
  5. Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center anal… Co-author DOI 10.21147/j.issn.1000-9604.2021.04.03↗
  6. Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China. Co-author PMID 34249444↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaodong Tian · 6 shared papers, 2021–2024 · strength 0.95
  2. Yongsu Ma · 4 shared papers, 2021–2024 · strength 0.68
  3. Yinmo Yang · 4 shared papers, 2021–2023 · strength 0.61
  4. Kai Chen · 2 shared papers, 2021–2024 · strength 0.34
  5. Yiran Chen · 2 shared papers, 2021–2022 · strength 0.30
  6. Feng Wang · 2 shared papers, 2021 · strength 0.27
  7. Hao Hu · 2 shared papers, 2021 · strength 0.25
  8. Xinxin Liu · 1 shared paper, 2024 · strength 0.20
  9. Dongqi Li · 1 shared paper, 2024 · strength 0.20
  10. Yinmo Yang · 1 shared paper, 2024 · strength 0.20
  11. Xiangyu Chu · 1 shared paper, 2024 · strength 0.20
  12. Bohan Yang · 1 shared paper, 2023 · strength 0.18
  13. Long Di · 1 shared paper, 2023 · strength 0.18
  14. Yingjin Wang · 1 shared paper, 2023 · strength 0.18
  15. Huahu Guo · 1 shared paper, 2021 · strength 0.14
  16. Yinmo Yang · 1 shared paper, 2021 · strength 0.14
  17. Mingzhe Li · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.